Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Reversible modulation of a deep white matter surgical target for depression with low-intensity focused ultrasound
    Published on 2025-09-25
    2 months ago
  • There is still so much work to be done: a mother’s perspective
    Published on 2025-09-25
    2 months ago
  • Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories
    Published on 2025-09-25
    2 months ago
  • Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes
    Published on 2025-09-25
    2 months ago
  • Optimizing social media initiatives to promote Neuropsychopharmacology (NPP) publications
    Published on 2025-09-24
    2 months ago
  • Reply to Kim and Jeong: Namesake of PF-05231023: how nomenclature confusion leads to experimental misinterpretation in pharmacologic research
    Published on 2025-09-24
    2 months ago
  • Moving from isolation to integration: a Bayesian multisensory perspective of interoception and psychosis
    Published on 2025-09-24
    2 months ago
« Previous 1 … 6 7 8 9 10 … 143 Next »
Journal of Psychopharmacology
  • Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment
    Published on 2025-09-17
    3 months ago
  • Loss of responsiveness on reinstatement of antidepressants after treatment interruption – A systematic review
    Published on 2025-09-13
    3 months ago
  • Concomitant use of antidepressants and classic psychedelics: A scoping review
    Published on 2025-09-12
    3 months ago
  • Rapid eye movement sleep: Who needs it? Creativity mechanisms and psychiatric applications of REM sleep enhancement
    Published on 2025-09-09
    3 months ago
  • Out of control: Blinding, dose response, and psychosocial controls in psychedelic trials
    Published on 2025-09-01
    3 months ago
  • Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial
    Published on 2025-08-30
    3 months ago
  • Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials
    Published on 2025-08-28
    3 months ago
« Previous 1 … 6 7 8 9 10 … 134 Next »
European Neuropsychopharmacology
  • Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine: A one-year retrospective cohort study of 2126 patients
    Published on 2025-08-07
    4 months ago
  • The genetics of treatment-resistant depression: controversies and perspectives
    Published on 2025-08-06
    4 months ago
  • Fifty years of pharmacotherapy for obsessive-compulsive disorder – A short reflection
    Published on 2025-08-06
    4 months ago
  • Editorial Board
    Published on 2025-07-25
    4 months ago
  • Therapygenetics: Serotonin transporter gene polymorphism (5-HTTLPR) is associated with behavioral treatment response to virtual exposure therapy in patients with spider phobia
    Published on 2025-07-16
    5 months ago
  • Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial
    Published on 2025-07-13
    5 months ago
  • Inflammation–neurotrophin interplay and depression outcomes: authors’ reply
    Published on 2025-07-12
    5 months ago
« Previous 1 … 6 7 8 9 10 … 153 Next »

   Pharma Pub